Organisation paid for research Program year 2025 Source: CMS Open Payments

Bexley Dermatology Research

Neither a doctor nor a teaching hospital

Research payments

$199,238

30 payments

Through program year 2025, Bexley Dermatology Research is reported as receiving $199,238 in research payments, across 30 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$26,668	2
2024	Research	$36,273	4
2023	Research	$43,487	5
2022	Research	$1,095	1
2021	Research	$63,769	1
2020	Research	$10,806	12
2019	Research	$17,141	5

Breakdown

Who paid Research payments · program years 2019–2025

Amgen Inc. $165,449 8 payments
Bausch Health US, LLC $17,141 5 payments
VYNE Pharmaceuticals Inc. $10,736 11 payments
E.R. Squibb & Sons, L.L.C. $4,391 3 payments
Pfizer Inc. $1,522 3 payments

Studies the money was for Research payments · program years 2019–2025

ABP 654 P3 PsO Study $63,769 1 payment
P3 AD Adult Combo TCS $29,526 1 payment
ASCEND P3 AD Extension $26,792 1 payment
A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND) $19,918 1 payment
Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Efficacysafety Study $17,141 5 payments
Mti-105 $10,736 11 payments
P3 AD Extension $10,433 1 payment
A Phase 3, Multicenter, Randomized, Open-label, Performance Study With Self-administered Subcutaneous Rocatinlimab (AMG 451) in Adolescent and Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Outpost) $6,749 1 payment
SHUTTLE P3 AD Adult Combo TCS $6,252 1 payment
A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED STUDY EVALUTING IMPACT OF DEUCRAVACITINIB ON QoL, EFFICACY AND SAFETY IN PATIENTS WITH PLAQUE PSORIASIS AND IMPAIRED HEALTH-RELATED QUALITY OF LIFE $3,296 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.